title: The economics of haemophilia prophylaxis: governmental and insurer perspectives. Proceedings of the Second International Prophylaxis Study Group (IPSG) symposium.
authors.affiliation: Department of Pediatrics, University of Toronto, and Division of Rheumatology, The Hospital for Sick Children, Toronto, Ontario, Canada. brian.feldman@sickkids.ca
authors.forename: B M
authors.initials: BM
authors.lastname: Feldman
authors.forename: L
authors.initials: L
authors.lastname: Aledort
authors.forename: M
authors.initials: M
authors.lastname: Bullinger
authors.forename: F M
authors.initials: FM
authors.lastname: Delaney
authors.forename: A S
authors.initials: AS
authors.lastname: Doria
authors.forename: S
authors.initials: S
authors.lastname: Funk
authors.forename: P
authors.initials: P
authors.lastname: Giangrande
authors.forename: B
authors.initials: B
authors.lastname: Lundin
authors.forename: M
authors.initials: M
authors.lastname: Manco-Johnson
authors.forename: A
authors.initials: A
authors.lastname: Miners
authors.forename: P C
authors.initials: PC
authors.lastname: Scriba
authors.forename: A
authors.initials: A
authors.lastname: Srivastava
authors.forename: W
authors.initials: W
authors.lastname: Schramm
authors.forename: V S
authors.initials: VS
authors.lastname: Blanchette
mesh_terms: D003362:Cost-Benefit Analysis; D006291:Health Policy; D006467:Hemophilia A / Q000191:economics* / Q000517:prevention & control* / Q000628:therapy; D006801:Humans; D007348:Insurance, Health; D009656:North America; D006113:United Kingdom